Regeneron Partially Admits to Infringing COVID Tech Patent Amidst Safe Harbor Claims

Respected pharmaceutical entity, Regeneron Pharmaceuticals Inc., partially conceded to infringing on a patent held by a California-based company in their efforts to create and test COVID-19 vaccines and treatments. This admission, however, comes with a firm stance from Regeneron that their potential liability would not encompass activities falling under a federal ‘safe harbor’. This term…

Read More

Navigating Legal Complexities of AI in Europe: Data Protection, IP, and Cybersecurity Challenges

With the rapid evolution in artificial intelligence (AI), organizations particularly based in Europe, face an increasingly challenging legal landscape. The intersection of AI with aspects of Intellectual Property (IP), data protection and regulation forms new horizons of potential litigation. In order to harness the real benefits of AI, organizations need to map a careful path,…

Read More

Strategic IP Enforcement: Mattel’s Publicity Power Move in the Barbie World

In the wake of the global box office triumph of the “Barbie” movie, pressing regulatory questions and intellectual property (IP) disputes within the spheres of marketing and entertainment have come under focus. Mattel, the firm behind the Barbie franchise, with its strategic IP enforcement approach, showcases how such strategies can double as publicity tools, augmenting…

Read More

Crypto Startup Battles Citadel Securities Trade Secrets Lawsuit in Ongoing International Dispute

A cryptocurrency startup, founded by two ex-employees of Citadel Securities, has requested a federal judge in New York to dismiss a trade secrets lawsuit filed by their former employer. The startup’s defense argues that the duo’s employment contracts stipulate that all disputes should be adjudicated in England. The ex-Citadel Securities employees have reportedly urged the…

Read More

IP Expert Returns to Hogan Lovells in Miami, Reinforcing Firm’s Legal Prowess

A former associate of Hogan Lovells, specializing in commercial litigation and intellectual property (IP), has returned to the firm in Miami after spending over four years at Pryor Cashman LLP, according to a recent announcement. This move strengthens Hogan Lovells’ legal team and showcases the firm’s commitment to bolstering its intellectual property offerings. The return…

Read More

Tiger King Tattoo Ruling Highlights Complex Landscape of Intellectual Property Law

In a recent verdict, a federal judge ruled that Netflix’s use of a distinctive tattoo image, prominently featured in the hit documentary series ‘Tiger King,’ does not amount to copyright infringement. This judgement comes as a significant legal development within the complex landscape of intellectual property law, underlining the rigidity of the current statutes and…

Read More

Kilpatrick Townsend & Stockton Welcomes New Trademark Expert Partner to NYC Office

Kilpatrick Townsend & Stockton LLP has recently expanded its burgeoning team by appointing a new partner in their New York branch. This recruit joins Kilpatrick from Mayer Brown, further bolstering the team’s expertise in trademark law, false advertising, and class action litigation. The new partner brings a wealth of experience and knowledge, which will undoubtedly…

Read More

Court Upholds Genomics Patents, Bolstering Intellectual Property Rights in Innovation-Driven Industries

In a significant development in the sphere of genomics legal cases on September 14, 2023, the U.S. District Court for the District of Delaware vetoed Parse Biosciences Inc.’s (Parse) attempt to dismiss a complaint lodged by 10x Genomics Inc. (10x) and the Board of Trustees of Leland Stanford Junior University (Stanford). Parse was accused of…

Read More

Photographer Cites Warhol Ruling in Appeal for Reconsideration in Tattoo Copyright Infringement Case

In a development that could potentially influence the intellectual property landscape, a photographer who initiated legal action against celebrity tattoo artist, Kat Von D, for copyright infringement asked a federal judge in California to reconsider her decision. The dispute centers around Von D’s use of the photographer’s portrait of legendary jazz musician Miles Davis for…

Read More

Sex Toy Manufacturer Awarded $12.8 Million in Landmark Patent Infringement Case

In a recent decision, a Delaware federal jury issued a ruling in favor of a sex toy manufacturer, allotting the company a substantial $12.8 million. This marked remedy arises from the jurors’ collective judgment that a competitor infringed on several of the plaintiff’s patents, specifically those relating directly to stimulation devices. Law360 provides more detailed…

Read More

Reevaluating Patent Eligibility: The Impact of American Axle v. Neapco on Intellectual Property Law

In a recent case closely followed by intellectual property attorneys, the District of Delaware reexamined the remaining dispute claims in American Axle v. Neapco, following an appeal and petition for certiorari to the Supreme Court. At stake was whether the disputed claims were invalid due to the lack of patent-eligible subject matter. Described in more…

Read More

AI and Copyright: The Impact of Human Input on Intellectual Property Rights

In the evolving landscape of artificial intelligence (AI), an important legal question arises related to intellectual property rights: when can human input render AI work copyrightable? The U.S. District Court for the District of Columbia recently deliberated this very question in the context of affirming the U.S. Copyright Office’s stance that work completely generated by…

Read More

Choosing the Right Court Reporting Agency for Complex Intellectual Property Litigation

Selecting an apt court reporting agency for your Intellectual Property (IP) case is pivotal to achieving a favorable outcome. According to a recent report on JD Supra, IP litigations are characterized by their complexity, high confidentiality, and substantial scale. Such cases frequently feature high-profile parties, source code considerations, and international depositions, necessitating a court reporting…

Read More

Sanofi Seeks Dismissal of Mylan’s Antitrust Claims in Battle for Diabetes Market

In escalating legal skirmishes over the U.S pharmaceutical market’s diabetes sector, Sanofi-Aventis U.S. is pressing a Pennsylvania federal court to discard allegations put forth by Mylan Pharmaceuticals. The claims by Mylan insist that Sanofi utilized unlawful discounts and patent litigation to effectively inhibit the entry of Mylan’s generic version of injectable insulin into the marketplace….

Read More